Filter posts

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments …

Patent Cases Down by 40% in 2014

The number of new patent cases filed in federal court has dropped by an astonishing …

The Washington Post: Are Patents the Problem?

Tamar Haspel, food columnist for the Washington Post, looks at the issue of seed patents …

BIO Submits Amicus Briefs in Braintree v. Novel, Gilead v. Natco, and Bristol-Myers Squibb v. Teva P...

BIO has submitted briefs in three recent cases which could significantly impair drug and biotechnology …

PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters.   After the Supreme Court’s decisions …

BIO Submits Comments on “Myriad” PTO Patent Guidance

On July 31st, BIO, alongside a group of international bioindustry trade associations submitted comments to …

What International Trade Agreements Have to Do with Innovation

Innovation is not just the life-blood of the biotech industry, it is the very premise …

Protecting your IP Overseas

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications …

US Public Organizations Leading Genomic Research, with Europe and Asia Catching Up

Since before the mapping of the human genome just over a decade ago, we have …

Supreme Court Enunciates New Indefiniteness Standard

The Supreme Court has once again reversed a decision by the Federal Circuit, in this …